Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 4
Submit an article Journal homepage
134
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

A systematic multidisciplinary initiative may reduce the need for blood products in patients with abnormally invasive placenta

Albaro José Nieto-Calvachea Abnormally Invasive Placenta Clinic, Fundación Valle del Lili, Cali, Colombia;b Clinical Postgraduate Department, Universidad ICESI, Cali, ColombiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5639-9127
ORCID Icon,
María Camila López-Girónc Clinical Research Center, Fundación Valle del Lili, Cali, ColombiaORCID Iconhttps://orcid.org/0000-0002-7846-7300
ORCID Icon,
Marcela Quintero-Santacruzd Blood Bank and Transfusion Service, Fundación Valle del Lili, Cali, Colombia
,
Adriana Messa Bryona Abnormally Invasive Placenta Clinic, Fundación Valle del Lili, Cali, Colombia;b Clinical Postgraduate Department, Universidad ICESI, Cali, Colombia
,
Juan Manuel Burgos-Lunaa Abnormally Invasive Placenta Clinic, Fundación Valle del Lili, Cali, Colombia;b Clinical Postgraduate Department, Universidad ICESI, Cali, Colombia
,
María Paula Echavarría-Davida Abnormally Invasive Placenta Clinic, Fundación Valle del Lili, Cali, Colombia;b Clinical Postgraduate Department, Universidad ICESI, Cali, Colombia
,
Leidy Lópeza Abnormally Invasive Placenta Clinic, Fundación Valle del Lili, Cali, Colombia
,
Carmenza Macia-Mejiaa Abnormally Invasive Placenta Clinic, Fundación Valle del Lili, Cali, Colombia;d Blood Bank and Transfusion Service, Fundación Valle del Lili, Cali, Colombia
&
Juan Pablo Benavides-Calvachea Abnormally Invasive Placenta Clinic, Fundación Valle del Lili, Cali, Colombia
 show all
Pages 738-744 | Received 06 Nov 2019, Accepted 14 Feb 2020, Published online: 23 Feb 2020

References

  • Stafford I, Belfort M. Placenta accreta, increta, and percreta: lifesaving strategies to stop the bleeding. Gynakol. 2008;53:48–53. 6p.
  • Zosmer N, Datta S, To M, et al. The morbidly adherent placenta: early accurate diagnosis is essential for the meaningful interpretation of outcomes. BJOG: Int J Obstet Gy. 2014;121(10):1314–1315.
  • Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212(5):561–568.
  • Chantraine F, Braun T, Gonser M, et al. Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand. 2013;92(4):439–444.
  • Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212(2):218.e1–218.e9.
  • Nieto AJ, Echavarría MP, Carvajal JA, et al. Placenta accreta: importance of a multidisciplinary approach in the Colombian hospital setting. J Matern Fetal Neonatal Med. 2020;33(8):1321–1329.
  • Palacios Jaraquemada JM, Pesaresi M, Nassif JC, et al. Anterior placenta percreta: surgical approach, hemostasis and uterine repair. Acta Obstet Gynecol Scand. 2004;83(8):738–744.
  • Chen X, Shan R, Song Q. et al. Placenta percreta evaluated by MRI: correlation with maternal morbidity. Arch Gynecol Obstet. 2020. doi: 10.1007/s00404-019-05420-5
  • Ordoñez CA, Manzano-Nunez R, Parra MW, et al. Prophylactic use of resuscitative endovascular balloon occlusion of the aorta in women with abnormal placentation: a systematic review, meta-analysis, and case series. J Trauma Acute Care Surg. 2018;84(5):809–818.
  • DeSimone RA, Leung WK, Schwartz J. Transfusion medicine in a multidisciplinary approach to morbidly adherent placenta: preparing for and preventing the worst. Transfus Med Rev. 2018;32(4):244–248.
  • Panigrahi AK, Yeaton-Massey A, Bakhtary S, et al. A standardized approach for transfusion medicine support in patients with morbidly adherent placenta. Anesth Analg. 2017;125(2):603–608.
  • Palacios-Jaraquemada JM, Fiorillo A, Hamer J, et al. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med. 2020;33:1–8.
  • Shamshirsaz AA, Fox KA, Erfani H, et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol. 2017;216(6):612.e1–612.e5.
  • Brookfield KF, Goodnough LT, Lyell DJ, et al. Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation. Transfusion. 2014;54(6):1530–1536.
  • O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996;175(6):1632–1638.
  • Nieto-Calvache AJ, Zambrano MA, Herrera NA, et al. Resective-reconstructive treatment of abnormally invasive placenta: Inter Institutional Collaboration by telemedicine (eHealth). J Matern Fetal Neonatal Med. 2019;32:1–9.
  • Patel A, Goudar SS, Geller SE, et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynecol Obstet. 2006;93(3):220–224.
  • Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 2010;116(4):835–842.
  • Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2012;120(3):528–537.
  • Busani S, Ghirardini A, Petrella E, et al. A challenging case of pregnancy with placenta accreta and very rare irregular antibodies versus Cromer blood group system: a case report. J Med Case Rep. 2015;9(1):112.
  • Stotler B, Padmanabhan A, Devine P, et al. Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 2011;51(12):2627–2633.
  • , Cahill AG, Beigi R, Heine RP, et al. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219(6):B2–B16.
  • Collaborators WT. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–2116.
  • Kremer M, Cortez C. Perioperative administration of tranexamic acid for placenta previa and accreta study (tappas). Obstet Gynecol. 2019;133:57S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.